Efficient DNA Fingerprinting Based on the Targeted Sequencing of Active Retrotransposon Insertion Sites Using a Bench-Top High-Throughput Sequencing Platform

Por Monden, Yuki, Yamamoto, Ayaka, Shindo, Akiko, Tahara, Makoto
Publicado em 2014

Incidence and Risk Factors of Hypomagnesemia in Head and Neck Cancer Patients Treated with Cetuximab

Por Enokida, Tomohiro, Suzuki, Shinya, Wakasugi, Tetsuro, Yamazaki, Tomoko, Okano, Susumu, Tahara, Makoto
Publicado no Front Oncol (2016)

Feasibility of Cisplatin/5-Fluorouracil and Panitumumab in Japanese Patients with Squamous Cell Carcinoma of the Head and Neck

Por Tahara, Makoto, Onozawa, Yusuke, Fujii, Hirofumi, Monden, Nobuya, Yana, Ikuo, Otani, Satoru, Hasegawa, Yasuhisa
Publicado em 2014

Rationale and design of LUX-Head & Neck 1: a randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell ca...

Por Machiels, Jean-Pascal H, Licitra, Lisa F, Haddad, Robert I, Tahara, Makoto, Cohen, Ezra EW
Publicado em 2014

Construction of a linkage map based on retrotransposon insertion polymorphisms in sweetpotato via high-throughput sequencing

Por Monden, Yuki, Hara, Takuya, Okada, Yoshihiro, Jahana, Osamu, Kobayashi, Akira, Tabuchi, Hiroaki, Onaga, Shoko, Tahara, Makoto
Publicado no Breed Sci (2015)

Evaluation of the impact of a flowchart-type leaflet for cancer inpatients

Por Suzuki, Shinya, Enokida, Tomohiro, Kobayashi, Takehiko, Yajima, Yoko, Ishiki, Hiroto, Izumi, Keishiro, Endo, Kazushi, Tahara, Makoto
Publicado no SAGE Open Med (2014)

Phase 1 study of trebananib (AMG 386), an angiogenesis targeting angiopoietin-1/2 antagonist, in Japanese patients with advanced solid tumors

Por Doi, Toshihiko, Ohtsu, Atsushi, Fuse, Nozomu, Yoshino, Takayuki, Tahara, Makoto, Shibayama, Kazuhiro, Takubo, Takatoshi, Weinreich, David M.
Publicado em 2012

Impact of early radiological response evaluation on radiotherapeutic outcomes in the patients with nasal cavity and paranasal sinus malignancies

Por Hojo, Hidehiro, Zenda, Sadamoto, Akimoto, Tetsuo, Kohno, Ryosuke, Kawashima, Mitsuhiko, Arahira, Satoko, Nishio, Teiji, Tahara, Makoto, Hayashi, Ryuichi, Sasai, Keisuke
Publicado em 2012

Phase III, randomized, open-label study of durvalumab (MEDI4736) monotherapy, or durvalumab + tremelimumab, versus standard of care (SoC), in recurrent or metastatic (R/M) squamous...

Por Ferris, Robert L, Even, Caroline, Haddad, Robert, Tahara, Makoto, Goswami, Trishna, Franks, April, Emeribe, Ugochi, Jarkowski, Anthony, Melillo, Giovanni, Licitra, Lisa
Publicado no J Immunother Cancer (2015)

Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604)

Por Tahara, Makoto, Fuse, Nozomu, Mizusawa, Junki, Sato, Akihiro, Nihei, Keiji, Kanato, Keisuke, Kato, Ken, Yamazaki, Kentaro, Muro, Kei, Takaishi, Hiromasa, Boku, Narikazu, Ohtsu, Atsushi
Publicado no Cancer Sci (2015)

Phase II Study of Cetuximab Plus Concomitant Boost Radiotherapy in Japanese Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Por Okano, Susumu, Yoshino, Takayuki, Fujii, Masato, Onozawa, Yusuke, Kodaira, Takeshi, Fujii, Hirofumi, Akimoto, Tetsuo, Ishikura, Satoshi, Oguchi, Masahiko, Zenda, Sadamoto, de Blas, Barbara, Tahara, Makoto
Publicado em 2013

Platinum-based Chemotherapy Plus Cetuximab for the First-line Treatment of Japanese Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: Results...

Por Yoshino, Takayuki, Hasegawa, Yasuhisa, Takahashi, Shunji, Monden, Nobuya, Homma, Akihiro, Okami, Kenji, Onozawa, Yusuke, Fujii, Masato, Taguchi, Takahide, de Blas, Barbara, Beier, Frank, Tahara, Makoto
Publicado em 2013

Subgroup analysis of Japanese patients in a phase 3 study of lenvatinib in radioiodine‐refractory differentiated thyroid cancer

Por Kiyota, Naomi, Schlumberger, Martin, Muro, Kei, Ando, Yuichi, Takahashi, Shunji, Kawai, Yasukazu, Wirth, Lori, Robinson, Bruce, Sherman, Steven, Suzuki, Takuya, Fujino, Katsuki, Gupta, Anubha, Hayato, Seiichi, Tahara, Makoto
Publicado no Cancer Sci (2015)

Characterization of Tumor Size Changes Over Time From the Phase 3 Study of Lenvatinib in Thyroid Cancer

Por Robinson, Bruce, Schlumberger, Martin, Wirth, Lori J., Dutcus, Corina E., Song, James, Taylor, Matthew H., Kim, Sung-Bae, Krzyzanowska, Monika K., Capdevila, Jaume, Sherman, Steven I., Tahara, Makoto
Publicado no J Clin Endocrinol Metab (2016)

Lenvatinib for Anaplastic Thyroid Cancer

Por Tahara, Makoto, Kiyota, Naomi, Yamazaki, Tomoko, Chayahara, Naoko, Nakano, Kenji, Inagaki, Lina, Toda, Kazuhisa, Enokida, Tomohiro, Minami, Hironobu, Imamura, Yoshinori, Sasaki, Tatsuya, Suzuki, Takuya, Fujino, Katsuki, Dutcus, Corina E., Takahashi, Shunji
Publicado no Front Oncol (2017)

Phase II trial of chemoradiotherapy with S-1 plus cisplatin for unresectable locally advanced head and neck cancer (JCOG0706)

Por Tahara, Makoto, Kiyota, Naomi, Mizusawa, Junki, Nakamura, Kenichi, Hayashi, Ryuichi, Akimoto, Tetsuo, Hasegawa, Yasuhisa, Iwae, Shigemichi, Monden, Nobuya, Matsuura, Kazuto, Fujii, Hirofumi, Onozawa, Yusuke, Homma, Akira, Kubota, Akira, Fukuda, Haruhiko, Fujii, Masato
Publicado no Cancer Sci (2015)

A prospective, multicenter phase I/II study of induction chemotherapy with docetaxel, cisplatin and fluorouracil (DCF) followed by chemoradiotherapy in patients with unresectable l...

Por Satake, Hironaga, Tahara, Makoto, Mochizuki, Satoshi, Kato, Ken, Hara, Hiroki, Yokota, Tomoya, Kiyota, Naomi, Kii, Takayuki, Chin, Keisho, Zenda, Sadamoto, Kojima, Takashi, Bando, Hideaki, Yamazaki, Tomoko, Iwasa, Satoru, Honma, Yoshitaka, Hamauchi, Satoru, Tsushima, Takahiro, Ohtsu, Atsushi
Publicado no Cancer Chemother Pharmacol (2016)